Quavonlimab (Anti-CTLA-4 / CD152)
A3020
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameQuavonlimab (Anti-CTLA-4 / CD152)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionQuavonlimab (Anti-CTLA-4 / CD152) is a monoclonal antibody targeting the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). It exhibits efficacy in first-line treatment of advanced non-small-cell lung cancer. MW :144.24 KD.
- Storage Instruction-20°C
- UNSPSC12352203